Summary: Glucagon-like peptide-1 receptor agonists are injectable or oral medicines that lower blood glucose in type 2 diabetes by stimulating insulin release, suppressing glucagon, slowing digestion, and reducing appetite, often leading to weight loss and cardiovascular benefits
6 weeks 6 vials ~25.2 mg total peptide needed
Increased localization of APP -C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease
B-12 injections bypass the digestive tract and deliver the vitamin directly into the bloodstream, ensuring quicker and more effective absorption
JAMA 331 , 740749 (2024)
The series investigates essential themescognitive bias, emotional regulation, digital attention, and meaning-makingrevealing how the modern mind adapts to information overload, uncertainty, and constant stimulation